Laser Systems in North Carolina

Axicon Technologies LLC is a manufacturer of aesthetic medical devices specializing in laser hair removal, non-invasive body contouring, and skin rejuvenation technology. The company develops state-of-the-art energy-based platforms including picosecond laser systems, CO2 ablative resurfacing, radiofrequency microneedling, high-intensity focused ultrasound (HIFU), and PEMF technology. All core products carry FDA and/or CE approvals, meeting regulatory standards for aesthetic and dermatological applications. The product portfolio includes the Juventas picosecond laser for tattoo removal and skin rejuvenation, Hemera CO2 laser for ablative resurfacing, EMAX Pro 3000 for multi-modality laser hair removal, Derma Sculpt HIFU for lifting and tightening, Green Diamond 532nm laser for body contouring and fat reduction, Aegle I radiofrequency system for cellulite and skin tightening, Cronus 8 RF microneedling device, ContourWave micro-vibration compression system, SportsX PEMF device for muscle stimulation, and Aerocool skin cooling system compatible with multiple energy-based platforms. The company positions its devices as user-friendly, customizable solutions for aesthetic practitioners and clinics seeking to offer transformative patient treatments with minimal downtime. Manufacturing capabilities include precision engineering of laser optics, radiofrequency delivery systems, and integrated cooling technologies. Axicon serves healthcare professionals globally, emphasizing research and development to maintain competitive technological advancement in the aesthetic medicine sector.

REVIAN is an FDA-cleared medical device manufacturer specializing in at-home phototherapy systems for hair loss treatment and scalp rejuvenation. The company produces wireless, LED-based low-level light therapy (LLLT) caps utilizing patented dual-wavelength red light technology (620nm orange and 660nm red wavelengths). REVIAN's flagship products—REVIAN Red and REVIAN Lyte—are clinically proven to stimulate hair regrowth by enhancing scalp microcirculation, reducing inflammation, and modulating nitric oxide production. The devices feature integrated mobile app control for treatment tracking, compliance monitoring, and progress documentation. A double-blind, placebo-controlled clinical trial demonstrated that REVIAN Red achieved 26.3 new hairs/cm² at 16 weeks, outperforming minoxidil and finasteride. The company maintains relationships with 2,000+ U.S. dermatology providers and offers HSA/FSA financing. Products are covered by a 6-month money-back guarantee (with 80% compliance) and are designed for daily 10-minute home use.